The Manufacturers Life Insurance Company Purchases 905 Shares of Phreesia, Inc. (NYSE:PHR)

The Manufacturers Life Insurance Company lifted its position in Phreesia, Inc. (NYSE:PHR) by 3.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 27,935 shares of the company’s stock after acquiring an additional 905 shares during the period. The Manufacturers Life Insurance Company’s holdings in Phreesia were worth $637,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. Trust Point Inc. raised its position in shares of Phreesia by 3.5% in the 3rd quarter. Trust Point Inc. now owns 17,887 shares of the company’s stock worth $408,000 after acquiring an additional 607 shares in the last quarter. Ensign Peak Advisors Inc raised its position in shares of Phreesia by 3.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 22,491 shares of the company’s stock worth $477,000 after acquiring an additional 700 shares in the last quarter. Rhumbline Advisers raised its position in shares of Phreesia by 1.0% in the 2nd quarter. Rhumbline Advisers now owns 82,136 shares of the company’s stock worth $1,741,000 after acquiring an additional 853 shares in the last quarter. nVerses Capital LLC increased its position in Phreesia by 76.5% during the 2nd quarter. nVerses Capital LLC now owns 3,000 shares of the company’s stock valued at $64,000 after buying an additional 1,300 shares in the last quarter. Finally, International Assets Investment Management LLC increased its position in Phreesia by 2,179.7% during the 3rd quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after buying an additional 1,395 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Canaccord Genuity Group reaffirmed a “buy” rating and set a $34.00 price objective on shares of Phreesia in a research report on Thursday, September 5th. Truist Financial raised their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $23.00 price objective on shares of Phreesia in a research report on Friday, September 27th. Robert W. Baird reduced their price objective on Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a research report on Wednesday. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a research report on Tuesday. One equities research analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $29.33.

Phreesia Stock Performance

Shares of PHR opened at $24.94 on Friday. The company has a market cap of $1.45 billion, a price-to-earnings ratio of -16.97 and a beta of 0.98. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $29.16. The company has a current ratio of 1.74, a quick ratio of 1.77 and a debt-to-equity ratio of 0.04. The business’s fifty day simple moving average is $20.45 and its two-hundred day simple moving average is $21.82.

Phreesia (NYSE:PHR) last released its quarterly earnings results on Monday, December 9th. The company reported ($0.25) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. The firm had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company’s revenue for the quarter was up 16.6% on a year-over-year basis. During the same period last year, the business posted ($0.58) EPS. Research analysts anticipate that Phreesia, Inc. will post -1.22 earnings per share for the current fiscal year.

Insider Transactions at Phreesia

In related news, insider Yvonne Hui sold 2,791 shares of Phreesia stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $20.92, for a total transaction of $58,387.72. Following the transaction, the insider now directly owns 27,228 shares in the company, valued at approximately $569,609.76. The trade was a 9.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP David Linetsky sold 11,853 shares of Phreesia stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $24.85, for a total value of $294,547.05. Following the transaction, the senior vice president now owns 188,354 shares in the company, valued at $4,680,596.90. This trade represents a 5.92 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 65,422 shares of company stock worth $1,417,561 in the last ninety days. Insiders own 5.80% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.